Oxygenta Pharmaceutical Ltd — Insider Trade, 01-01-1970: Insider Trading / SAST

The company has announced a board meeting to consider the financial results for the quarter and half-year. This update signals upcoming disclosure of performance metrics that could impact investor sentiment and market valuation. No further financial details or operational changes were disclosed at this stage, keeping stakeholders attentive to the forthcoming results for insight into the company’s recent business performance.